{"first_name":"Jean-FranÃ§ois","last_name":"LabbÃ©","permalink":"jean-franois-labb","crunchbase_url":"http://www.crunchbase.com/person/jean-franois-labb","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Jun 22 09:35:40 UTC 2009","updated_at":"Mon Jun 22 09:37:12 UTC 2009","overview":"<p>Prior to founding SpePharm Jean-FranÃ§ois LabbÃ© was an investor in and CEO of OTL Pharma, a Paris-based specialty pharmaceutical and orphan drug company, which achieved â‚¬14M sales in 2004, the year he sold the business to Strakan (now ProStrakan). Jean-FranÃ§ois has worked for over 30 years in the pharmaceutical industry and was previously CEO of Parke Davis France. Prior to joining Parke Davis, Jean-FranÃ§ois worked for Hoechst-Roussel for 25 years where he held various general management positions in Europe (The Netherlands, France, UK) and abroad (USA, South Africa).</p>","image":{"available_sizes":[[[93,120],"assets/images/resized/0005/0065/50065v1-max-150x150.png"],[[93,120],"assets/images/resized/0005/0065/50065v1-max-250x250.png"],[[93,120],"assets/images/resized/0005/0065/50065v1-max-450x450.png"]],"attribution":""},"degrees":[{"degree_type":"MBA","subject":"","institution":"HEC business school","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Managing Director and Chief Executive Officer","firm":{"name":"SpePharm","permalink":"spepharm","type_of_entity":"company","image":{"available_sizes":[[[150,45],"assets/images/resized/0005/0063/50063v1-max-150x150.png"],[[239,72],"assets/images/resized/0005/0063/50063v1-max-250x250.png"],[[239,72],"assets/images/resized/0005/0063/50063v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}